IMEGLIMIN with Novel Process
IMEGLIMIN (Brand Name TWYMEEG) IS AN ORAL ANTI-DIABETIC MEDICATION.
A NEAR TERM LAUNCH OPPORTUNITY FOR GENERIC PHARMA MANUFACTURERS.
